STOCK TITAN

Globus Medical Inc - GMED STOCK NEWS

Welcome to our dedicated news page for Globus Medical (Ticker: GMED), a resource for investors and traders seeking the latest updates and insights on Globus Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Globus Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Globus Medical's position in the market.

Rhea-AI Summary
Globus Medical launches Precice Bone Transport system in select markets, positively impacting over 250 trauma and oncology patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.79%
Tags
none
-
Rhea-AI Summary
Globus Medical completes merger with NuVasive, creating a leading global musculoskeletal company. The merger offers compelling upside revenue potential and a strong financial profile for value creation. NuVasive common stock ceased trading on Nasdaq.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags
Rhea-AI Summary
GMED: Globus Medical Launches MARVEL™ Growing Rod System for Pediatric Scoliosis Treatment - Globus Medical, Inc. (NYSE: GMED) has announced the commercial launch of the MARVEL™ Growing Rod System, designed for pediatric patients with early onset scoliosis. The system features a powerful geared mechanism for reliable lengthening, PEEK polymer bearing surfaces, and a minimally invasive procedure. The product is part of the company's commitment to providing solutions for complex spinal disorders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.1%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.03%
Tags
-
Rhea-AI Summary
Globus Medical's REFLECT™ Scoliosis Correction System receives FDA approval as the company's first humanitarian device. The system is designed to correct progressive scoliosis in young patients while preserving motion and allowing for future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.29%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
Globus Medical Inc

NYSE:GMED

GMED Rankings

GMED Stock Data

6.99B
111.92M
0.79%
96.92%
5.73%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Audubon

About GMED

globus medical, inc. is a leading musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. founded in 2003, globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with spinal disorders. additional information can be accessed at www.globusmedical.com.